DAVID S. SNYDER - 09 Jan 2025 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Chief Financial Officer
Signature
/s/ David Snyder
Issuer symbol
COYA
Transactions as of
09 Jan 2025
Net transactions value
$0
Form type
4
Filing time
13 Jan 2025, 08:00:07 UTC
Previous filing
14 Nov 2024
Next filing
26 Jan 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award $0 +140,562 $0.000000 140,562 09 Jan 2025 Common Stock, par value $0.0001 per share 140,562 $6.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date.